UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 19, 2023

NanoVibronix, Inc.

(Exact name of registrant as specified in its charter)

Delaware

(State or other jurisdiction of incorporation)

001-3644501-0801232
(Commission
File Number)
(IRS Employer
Identification No.)

525 Executive Blvd., Elmsford, NY10523

(Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code: (914)233-3004

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.001 per share NAOV NasdaqCapital Market
Item 8.01.Other Events.

As previously reported on May 25, 2023, NanoVibronix, Inc. (the "Company") was notified by the staff of the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") that it no longer satisfied Nasdaq Listing Rule 5550(b)(1) (the "Rule"), which requires a minimum of $2.5 million in stockholders' equity for continued listing on The Nasdaq Capital Market. The Company thereafter presented its plan to regain compliance with the Rule and, on July 19, 2023, the Staff granted the Company's request for continued listing pursuant to an extension through November 20, 2023, to evidence compliance with the Rule.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: July 20, 2023 NANOVIBRONIX, Inc.
By:/s/ Stephen Brown
Name: Stephen Brown
Title: Chief Financial Officer

Attachments

Disclaimer

NanoVibronix Inc. published this content on 20 July 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 July 2023 22:10:47 UTC.